Maximize your treatment of alcohol-associated liver disease. Learn how to evaluate liver disease in patients with alcohol use disorder (AUD), choose AUD medications that are safe and effective, and identify patients who may be eligible for early liver transplantation. We’re joined by Dr. Lamia Haque, @lykhaque (Yale School of Medicine).
We are thrilled to produce Season 3 with support and partnership from The American College of Academic Addiction Medicine (ACAAM)!
Claim CME for this episode at curbsiders.vcuhealth.org!
By listening to this episode and completing CME, this can be used to count towards the new DEA 8-hr requirement on substance use disorders education.
Episodes | Subscribe | Spotify | iTunes |
[email protected] | Free CME!
Show Segments
Intro, disclaimer, guest bio 0:00 Guest one-liner 3:10Case from Kashlak 6:30Epidemiology of alcohol-associated liver disease (ALD) 7:40How does alcohol affect the liver? 11:11Spectrum of ALD 13:10Risk factors for ALD 16:13Evaluating for ALD 19:35When to refer to hepatology 33:08Medications for AUD in patients with ALD 37:00Monitoring liver tests for naltrexone 44:27Optimizing treatment for patients who continue drinking 47:18ALD and liver transplantation 50:45Post-transplant care 1:00:15Take-home points 1:02:30Outro 1:04:56Credits
Writer and Producer: Kenneth Morford, MDShow Notes: Kenneth Morford, MDInfographic and Cover Art: Natalie Stahl, MD, MPHHosts: Carolyn Chan, MD. MHS and Kenneth Morford, MDReviewer: Sarah Leyde, MDShowrunner: Carolyn Chan, MD, MHSTechnical Production: PodPasteGuest: Lamia Haque, MD, MPH